Optimizing oral absorption of peptides using prodrug strategies
- 1 November 1999
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 62 (1-2), 231-238
- https://doi.org/10.1016/s0168-3659(99)00042-5
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Improvement of oral peptide bioavailability: Peptidomimetics and prodrug strategiesAdvanced Drug Delivery Reviews, 1997
- Peptide Targeting and Delivery across the Blood−Brain Barrier Utilizing Synthetic Triglyceride Esters: Design, Synthesis, and BioactivityBioconjugate Chemistry, 1997
- Prodrug strategies to enhance the intestinal absorption of peptidesDrug Discovery Today, 1997
- Effect of Size and Charge on the Passive Diffusion of Peptides Across Caco-2 Cell Monolayers via the Paracellular PathwayPharmaceutical Research, 1997
- How Structural Features Influence the Biomembrane Permeability of PeptidesJournal of Pharmaceutical Sciences, 1996
- Prodrugs of peptides and peptidomimetics for improved formulation and deliveryAdvanced Drug Delivery Reviews, 1996
- Synthesis and biological properties of gamma-glutamyl-dermorphin, a prodrugLife Sciences, 1996
- Development of Receptor-Selective Opioid Peptide Analogs as Pharmacologic Tools and as Potential DrugsPublished by Springer Nature ,1993
- Opioid peptide interactions with lipid bilayer membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1992
- Recent developments in the design of receptor specific opioid peptidesMedicinal Research Reviews, 1989